Table 2 Cost savings and utility gains of the test strategy compared with the usual care strategy for different adherence assumptions for 1000 patients
Adherence rate, % | Cost saving (loss), $ | QALYs gained |
|---|---|---|
1 | (72,332) | 0.7 |
2 | (55,331) | 1.1 |
3 | (38,330) | 1.5 |
4 | (21,329) | 2.0 |
5 | (4,328) | 2.4 |
7.5 | 38,175 | 3.5 |
10 | 80,678 | 4.5 |
15 | 165,683 | 6.7 |
20 | 250,689 | 8.8 |
25 | 335,694 | 11.0 |
30 | 420,699 | 13.1 |
40 | 590,710 | 17.5 |
50 | 760,721 | 21.8 |